TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/14/25 09:00 | 4/10/25 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sander Dale A. | NC | O | CFO,Chie | P | 31 | 1.53 | 0 | 20 | 88 | 43 | I | ||||||||||||||
8/29/24 18:45 | 8/27/24 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sander Dale A. | NC | O | CFO,Chie | M.d | 101 | 2.56 | 0 | 39 | 23 | D | |||||||||||||||
8/29/24 18:45 | 8/27/24 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sander Dale A. | NC | O | CFO,Chie | S.d | -263 | 6.68 | 0 | -39 | -64 | 23 | D | ||||||||||||||
12/19/22 20:29 | 12/16/22 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sander Dale A. | NC | O | CFO,Chie | P | 52 | 2.60 | 0 | 20 | 769 | 23 | I | ||||||||||||||
5/18/22 18:16 | 5/17/22 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sander Dale A. | NC | O | CFO,Chie | P | 9 | 4.53 | 0 | 2 | New | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |